Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trial

Hyun Goo Kang

Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trial

Translated title of the contribution: Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trial

Hyun Goo Kang

Department of Medicine

Research output: Contribution to journal › Journal article › peer-review

Translated title of the contribution	Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trial
Original language	Undefined/Unknown
Journal	Contemporary Clinical Trials
State	Published - 2026.01.1

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{2c593460bf4f4634b0ae69022139d3cd,

title = "Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trial",

author = "Kang, \{Hyun Goo\}",

year = "2026",

month = jan,

day = "1",

language = "Undefined/Unknown",

journal = "Contemporary Clinical Trials",

issn = "1551-7144",

}

Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trial. / Kang, Hyun Goo.
In: Contemporary Clinical Trials, 01.01.2026.

Research output: Contribution to journal › Journal article › peer-review

TY - JOUR

T1 - Comparison of clopidogrel-based antiplatelet therapy versus warfarin as a secondary prevention strategy for AntiPhospholipid Syndrome-related STROKE (APS-STROKE): Rationale and design of a prospective, randomized, open-label, blinded-endpoint trial

AU - Kang, Hyun Goo

PY - 2026/1/1

Y1 - 2026/1/1

M3 - Journal article

SN - 1551-7144

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

ER -